Skip to main content

DNAPrint Acquires Trace Genetics in All-Stock Deal

NEW YORK, June 21 (GenomeWeb News) - DNAPrint Genomics has acquired Trace Genetics in an all-stock transaction, DNAPrint said today.

 

Shareholders in Trace Genetics, a provider of services for forensics and geneology reserach, exchanged all outstanding shares of Trace for 25 million shares of DNAPrint common stock and options to purchase 5 million additional shares at $0.02 per share, DNAPrint said.

 

DNAPrint trades on the over-the-counter bulletin board. The company's stock closed at $0.01 yesterday, and remained unchanged following the announcement.

 

DNAPrint, based in Sarasota, Fla., said that the acquisition of the San Francisco-based Trace will provide it with an operating base on the West coast. Trace also brings two complementary technologies -- y-chromosome testing and mitochondrial x-chromosome testing -- to DNAPrint's genealogy products, DNAPrint said.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.